Cefotaxime Sodium/Tazobactam Sodium

头孢噻肟钠/他唑巴坦钠

Report date: 2026/04/21 20:00:18

Base Information

Drug NameCefotaxime Sodium/Tazobactam Sodium
Drug Alias NameN/A
ClassificationSmall molecules > Heterocyclic drugs > Antibiotics > β-lactam antibiotics
Mechanisms of ActionBacterial penicillin-binding protein inhibitorsCell wall inhibitorsBeta Lactamase inhibitors
TargetsBacterial penicillin-binding proteinBeta Lactamase
Therapy Area/IndicationsLower Respiratory Tract InfectionsPyelonephritisPulmonary Disease, Chronic Obstructive +[10] 
Global Approved IndicationsUrinary Tract Infections
Approved Indications in ChinaUrinary Tract Infections
Original Approved Country/TerritoryMainland China
Original Approved Date2021/10/19
Country/TerritoryMainland China
CombinationsYes Cefotaxime SodiumTazobactam Sodium
Global Highest StatusApproved
Highest Status in ChinaApproved
Originator CompaniesNanjing Yoko Pharmaceutical Co Ltd
China Registration ClassN/A

Develop Information

Active CompaniesHainan Zhonghemei Technology Co LtdNanjing Yoko Pharmaceutical Co Ltd
Inactive CompaniesNanjing Chang'Ao Pharmaceutical Co LtdNanjing Mingsheng Pharmaceutical Technology Co LtdNanjing Yoko Biomedical Co Ltd +[6] 
Active IndicationsUrinary Tract InfectionsRespiratory Tract Infections
Inactive IndicationsLower Respiratory Tract InfectionsPyelonephritisPulmonary Disease, Chronic Obstructive +[8] 

Other Information

ATC CodeN/A
Related LinksN/A